Mesalamine

"Mesalamine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

MeSH information

Definition | Details | More General Concepts | Related Concepts | More Specific Concepts

An anti-inflammatory agent, structurally related to the SALICYLATES, which is active in INFLAMMATORY BOWEL DISEASE. It is considered to be the active moiety of SULPHASALAZINE. (From Martindale, The Extra Pharmacopoeia, 30th ed)

Descriptor ID

D019804

MeSH Number(s)

D02.241.223.100.380.800.050.540

D02.241.511.390.700.050.500

D02.755.410.700.050.500

Concept/Terms

Mesalamine Hydrochloride

Mesalamine Monosodium Salt

Below are MeSH descriptors whose meaning is more general than "Mesalamine".

Chemicals and Drugs [D]
Organic Chemicals [D02]
Carboxylic Acids [D02.241]
Acids, Carbocyclic [D02.241.223]
Benzoic Acids [D02.241.223.100]
Hydroxybenzoic Acids [D02.241.223.100.380]
Salicylic Acids [D02.241.223.100.380.800]
Aminosalicylic Acids [D02.241.223.100.380.800.050]
Mesalamine [D02.241.223.100.380.800.050.540]
Hydroxy Acids [D02.241.511]
Hydroxybenzoic Acids [D02.241.511.390]
Salicylic Acids [D02.241.511.390.700]
Aminosalicylic Acids [D02.241.511.390.700.050]
Mesalamine [D02.241.511.390.700.050.500]
Phenols [D02.755]
Hydroxybenzoic Acids [D02.755.410]
Salicylic Acids [D02.755.410.700]
Aminosalicylic Acids [D02.755.410.700.050]
Mesalamine [D02.755.410.700.050.500]

Below are MeSH descriptors whose meaning is related to "Mesalamine".

Below are MeSH descriptors whose meaning is more specific than "Mesalamine".

publications

Timeline | Most Recent

This graph shows the total number of publications written about "Mesalamine" by people in Harvard Catalyst Profiles by year, and whether "Mesalamine" was a major or minor topic of these publication.

Bar chart showing 72 publications over 25 distinct years, with a maximum of 8 publications in 2018

To see the data from this visualization as text, click here.

Year	Major Topic	Minor Topic	Total
1993	0	3	3
1995	0	2	2
1996	0	1	1
1997	1	0	1
1998	0	3	3
1999	3	0	3
2000	1	0	1
2002	1	0	1
2004	2	0	2
2005	1	0	1
2006	2	0	2
2007	2	1	3
2008	1	2	3
2009	1	0	1
2010	2	0	2
2011	4	2	6
2012	1	2	3
2013	2	1	3
2014	4	1	5
2015	4	1	5
2016	3	1	4
2017	1	1	2
2018	5	3	8
2019	2	4	6
2022	0	1	1

Below are the most recent publications written about "Mesalamine" by people in Profiles.

The safety of paternal and maternal use of 5-aminosalicylic acid during conception and pregnancy: a nationwide cohort study. Aliment Pharmacol Ther. 2022 11; 56(9):1349-1360.

View in: PubMed
Early Change in Fecal Calprotectin Predicts One-Year Outcome in Children Newly Diagnosed With Ulcerative Colitis. J Pediatr Gastroenterol Nutr. 2022 01 01; 74(1):72-78.

View in: PubMed
Discordance Between Patient-Reported Outcomes and Mucosal Inflammation in Patients With Mild to Moderate Ulcerative Colitis. Clin Gastroenterol Hepatol. 2020 07; 18(8):1760-1768.e1.

View in: PubMed
The effects of di-butyl phthalate exposure from medications on human sperm RNA among men. Sci Rep. 2019 08 27; 9(1):12397.

View in: PubMed
Longitudinal non-adherence predicts treatment escalation in paediatric ulcerative colitis. Aliment Pharmacol Ther. 2019 10; 50(8):911-918.

View in: PubMed
Use, effectiveness and tolerability of budesonide-MMX in ulcerative colitis: A real-life experience. United European Gastroenterol J. 2019 11; 7(9):1164-1170.

View in: PubMed
Plasma N-terminal pro-B-type natriuretic peptide (BNP) in mesalazine-induced myopericarditis. BMJ Case Rep. 2019 Apr 11; 12(4).

View in: PubMed
Clinical and biological predictors of response to standardised paediatric colitis therapy (PROTECT): a multicentre inception cohort study. Lancet. 2019 04 27; 393(10182):1708-1720.

View in: PubMed
ACG Clinical Guideline: Ulcerative Colitis in Adults. Am J Gastroenterol. 2019 03; 114(3):384-413.

View in: PubMed
Improvement of the therapeutic treatment of inflammatory bowel diseases following rectal administration of mesalazine-loaded chitosan microparticles vs Asamax®. Carbohydr Polym. 2019 May 15; 212:430-438.

View in: PubMed

Related Networks

People

Explore

Similar Concepts

Top Journals

Inflamm Bowel Dis
Am J Gastroenterol
J Pediatr Gastroenterol Nutr
Gastroenterology
J Crohns Colitis
Dig Dis Sci
Scand J Gastroenterol
Digestion
Aliment Pharmacol Ther
BMJ Case Rep